Niren Shah, Pharm.D., MBA
VP of Business Operations and Chief of Staff
Brings over a decade of rare disease industry expertise to Taysha; with experience at Novartis, NPS Pharma, most recently focused on M&A and strategic in-licensing of multiple CNS gene therapy assets while in business development at PTC Therapeutics.